← Back to Search

Behavioural Intervention

No Proactive ILI content & Predictions for Coronavirus

N/A

Waitlist Available

Led By Ernesto H.N. Ramirez, PhD

Research Sponsored by Evidation Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years or older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, approximately 10 months

Awards & highlights

Study Summary

This trial aims to test a computer program that can predict when someone might have the flu and send them alerts. The study wants to see if this program can help people make better choices to prevent getting sick

Who is the study for?

This trial is for adults in the U.S. who are members of the Evidation platform, own and use a wearable activity tracker like an Apple Watch, Garmin, or Fitbit linked to their account, and have sufficient recent data from their device. People can't join if they're under 18, don't live in the U.S., don't have a linked activity tracker, or are already in certain other ILI studies.Check my eligibility

What is being tested?

The study tests whether getting predictive alerts about influenza-like illness (ILI) helps people adopt protective behaviors during flu season. Participants will be randomly assigned to receive different combinations of alerts and educational content or no intervention at all.See study design

What are the potential side effects?

Since this trial involves digital health education interventions rather than medications or medical procedures, traditional physical side effects are not expected. However, participants may experience information overload or anxiety from frequent health alerts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, approximately 10 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, approximately 10 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, approximately 10 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The primary objective of this study is to assess the effectiveness of a predictive ILI detection algorithm and associated alerts on ILI-related health and behavioral outcomes

Secondary outcome measures

The secondary objective is to assess the accuracy of an ILI detection algorithm using self-reported symptoms and ILI diagnosis

Other outcome measures

The exploratory objective is to assess differences in effectiveness between the four groups on ILI-related health and behavioral outcomes

Trial Design

4Treatment groups

Experimental Treatment

Group I: Proactive ILI content & PredictionsExperimental Treatment1 Intervention

Participants will receive predictive alerts, reactive content after reporting symptoms or receiving an asymptomatic prediction, and ILI-related health educational content

Group II: Proactive ILI content & No PredictionsExperimental Treatment1 Intervention

Participants will not receive predictive alerts or reactive content after reporting symptoms but will receive proactive ILI content

Group III: No Proactive ILI content & PredictionsExperimental Treatment1 Intervention

Participants will receive predictive alerts and reactive content after reporting symptoms or receiving an asymptomatic prediction, but will not receive proactive ILI content

Group IV: No Proactive ILI content & No PredictionsExperimental Treatment1 Intervention

Participants will not receive predictive alerts or reactive content after reporting symptoms or proactive ILI content

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

No Intervention

2017

Completed Phase 1

~4840

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Evidation HealthLead Sponsor

19 Previous Clinical Trials

252,282 Total Patients Enrolled

Biomedical Advanced Research and Development AuthorityFED

81 Previous Clinical Trials

894,441 Total Patients Enrolled

Ernesto H.N. Ramirez, PhDPrincipal InvestigatorEvidation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there ongoing efforts to actively enroll participants for this clinical trial?

"As indicated by the information available on clinicaltrials.gov, this trial is no longer actively seeking participants. The trial was originally posted on January 1st, 2024 and last updated on January 19th, 2024. However, it's worth noting that there are currently a total of 405 other studies enrolling participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI

2024. "Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06229444.

All > Influenza